Cancer and Excess Iron

  • Shinya ToyokuniEmail author


A 62-year-old male presented transient loss of consciousness during dialysis and was transferred to the emergency room. Chest X-ray and computed tomography revealed prominent right pleural effusion with large tumor mass surrounding the contour of the right lung. The patient had been involved in demolition work of old buildings and water pipes for more than 25 years, where he was often exposed to asbestos fibers in the air. The patient suffered from diabetes mellitus for 18 years and started dialysis three times a week since 7 years ago due to diabetic nephropathy.


Iron Asbestos Mesothelioma Oxygen Reactive oxygen species (ROS) 


  1. Akatsuka S, Yamashita Y, Ohara H, Liu YT, Izumiya M, Abe K, Ochiai M, Jiang L, Nagai H, Okazaki Y, Murakami H, Sekido Y, Arai E, Kanai Y, Hino O, Takahashi T, Nakagama H, Toyokuni S (2012) Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS One 7:e43403CrossRefGoogle Scholar
  2. Chew SH, Toyokuni S (2015) Malignant mesothelioma as an oxidative stress-induced cancer: an update. Free Radic Biol Med 86:166–178CrossRefGoogle Scholar
  3. Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O (1986) Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum- nitrilotriacetate complexes in rats. J Natl Cancer Inst 76:107–113PubMedGoogle Scholar
  4. Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, Eames KT, Edmunds WJ, Frost SD, Funk S (2015) Modeling infectious disease dynamics in the complex landscape of global health. Science 347:aaa4339CrossRefGoogle Scholar
  5. Hwang HC, Sheffield BS, Rodriguez S, Thompson K, Christopher HT, Gown AM, Churg A (2016) Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens. Am J Surg Pathol 40:120–126CrossRefGoogle Scholar
  6. IARC, WHO 2012. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite, and anthophyllite). IARC monographs on the evaluation of carcinogenic risks to humans a review of human carcinogens; part C: arsenic, metals, fibres, and dusts. Lyon, FranceGoogle Scholar
  7. Jiang L, Akatsuka S, Nagai H, Chew SH, Ohara H, Okazaki Y, Yamashita Y, Yoshikawa Y, Yasui H, Ikuta K, Sasaki K, Kohgo Y, Hirano S, Shinohara Y, Kohyama N, Takahashi T, Toyokuni S (2012) Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol 228:366–377CrossRefGoogle Scholar
  8. Kato J, Miyanishi K, Kobune M, Nakamura T, Takada K, Takimoto R, Kawano Y, Takahashi S, Takahashi M, Sato Y, Takayama T, Niitsu Y (2007) Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J Gastroenterol 42:830–836CrossRefGoogle Scholar
  9. Nagai H, Ishihara T, Lee WH, Ohara H, Okazaki Y, Okawa K, Toyokuni S (2011a) Asbestos surface provides a niche for oxidative modification. Cancer Sci 102:2118–2125CrossRefGoogle Scholar
  10. Nagai H, Okazaki Y, Chew S, Misawa N, Yamashita Y, Akatsuka S, Yamashita K, Ishihara T, Yoshikawa Y, Jiang L, Ohara H, Takahashi T, Ichihara G, Kostarelos K, Miyata Y, Shinohara H, Toyokuni S (2011b) Diameter of multi-walled carbon nanotubes is a critical factor in mesothelial injury and subsequent carcinogenesis. Proc Natl Acad Sci U S A 108:E1330–E1338CrossRefGoogle Scholar
  11. Ohara Y, Chew S-H, Shibata T, Okazaki Y, Yamashita K, Toyokuni S (2018) Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats. Cancer Sci 109(2):330–339CrossRefGoogle Scholar
  12. Oury TD, Sporn TA, Roggli VL (2014) Pathology of asbestos-associated diseases, 3rd edn. Springer-Verlag Berlin Heiderberg, New YorkCrossRefGoogle Scholar
  13. Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5–29CrossRefGoogle Scholar
  14. Toyokuni S (1996) Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20:553–566CrossRefGoogle Scholar
  15. Toyokuni S (1999) Reactive oxygen species-induced molecular damage and its applicaton in pathology. Pathol Int 49:91–102CrossRefGoogle Scholar
  16. Toyokuni S (2009a) Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci 71:1–10PubMedGoogle Scholar
  17. Toyokuni S (2009b) Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 100:9–16CrossRefGoogle Scholar
  18. Toyokuni S (2011) Iron as a target of chemoprevention for longevity in humans. Free Radic Res 45:906–917CrossRefGoogle Scholar
  19. Toyokuni S (2016) The origin and future of oxidative stress pathology: From the recognition of carcinogenesis as an iron addiction with ferroptosis-resistance to non-thermal plasma therapy. Pathol Int 66:245–259CrossRefGoogle Scholar
  20. Toyokuni S (2018) Iron addiction with ferroptosis-resistance in asbestos-induced mesothelial carcinogenesis: toward the era of mesothelioma prevention. Free Radic Biol Med.
  21. Toyokuni S, Ito F, Yamashita K, Okazaki Y, Akatsuka S (2017) Iron and thiol redox signaling in cancer: an exquisite balance to escape ferroptosis. Free Radic Biol Med 108:610–626CrossRefGoogle Scholar
  22. Weinberg R (2013) The biology of cancer. Garland Science, New YorkGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Pathology and Biological ResponsesNagoya University Graduate School of MedicineNagoyaJapan

Personalised recommendations